Associated Papers
Molecular profiling of patients with colorectal cancer and matched targeted therapy in phase I clinical trials.
Dienstmann R et al.
Molecular Cancer Therapeutics, 2012
ERK inhibition overcomes acquired resistance to MEK inhibitors.
Hatzivassiliou G et al.
Molecular Cancer Therapeutics, 2012
BRAF and NRAS mutations in melanoma: potential relationships to clinical response to HSP90 inhibitors.
Banerji U et al.
Molecular Cancer Therapeutics, 2008
Structural heterogeneity of type I collagen triple helix and its role in osteogenesis imperfecta.
Makareeva E et al.
The Journal of Biological Chemistry, 2008
Select a paper to view details